. 2016 Jan 7;82(2):223–231. doi: 10.1016/j.bjorl.2015.05.018

Table 2.

Changes with clinical treatment.

Authors and year	Nasal resistance	Snoring after the intervention	Clinical improvement	Polysomnography after intervention	AHI and SDBI	Arousal index
Kiely et al. 2004	Reduction^a with active treatment.	No reduction.	Improved daytime alert by the daily record and quality of sleep.	Limited effect in the treatment of OSAS.	AHI and desaturation index decreased^a with fluticasone.	Not reported.
Kiely et al. 2004	Reduction^a with active treatment.	No reduction.		Increase^a of SWS.	AHI and desaturation index decreased^a with fluticasone.	Not reported.
Lean et al. 2005	Reduction^a with active treatment.	Not reported.	Reduction^a of mouth breathing during sleep and partial improvement of sleep quality.	Improvement^a of sleep efficiency.	No reduction.	Reduction^a with active treatment.
Lean et al. 2005	Reduction^a with active treatment.	Not reported.	No reduction in ESS.	Increase^a in REM and SWS.	No reduction.	Reduction^a with active treatment.
Clarenbach et al. 2008	Reduction^a with active treatment.	No reduction.	No reduction in ESS.	No alteration in SWS or REM.	No reduction.	No reduction.

AHI, apnea and hypopnea index; SDBI, sleep-disordered breathing index; ESS, Epworth Sleepiness Scale; SWS, slow-wave sleep; CPAP, continuous positive airway pressure; desaturation index, number of desaturations ≥4% per hour of sleep.

Statistically significant difference.